# HARMONICS: feasibility of a holistic value-based care hybrid programme that maximises clinical outcomes after stroke

**Authors:** Marta Rubiera, Alvaro Garcia-Tornel, Marian Muchada, Francisco Purroy, Joao Sargento-Freitas, Xavier Ustrell, Alejandro Bustamante, Yolanda Silva, Maria Dolors Alsina, Cristina Girao, Gerard Mauri, Sara Bernardo-Castro, Noelia Canela, Elia Dolz, Elisabeth Ortiz, Giorgio Colangelo, David Cano, Marc Ribo, Carlos A Molina

PMC · DOI: 10.1093/esj/aakag016 · European Stroke Journal · 2026-03-17

## TL;DR

HARMONICS is a new care model for stroke survivors that improves outcomes through coordinated follow-up and patient engagement.

## Contribution

HARMONICS introduces a feasible hybrid care model integrating clinician and patient-reported outcomes for post-stroke follow-up.

## Key findings

- HARMONICS achieved high recruitment and retention rates across six stroke centers in Spain and Portugal.
- Patients in HARMONICS showed better 3-month mRS outcomes and improved PROMs compared to historical controls.
- Despite success in most metrics, PROMs completion at 90 days fell below the target threshold.

## Abstract

The increasing number of stroke survivors underscores the need for coordinated post-discharge care and systematic outcome monitoring. HARMONICS aimed to provide standardised follow-up, integrating clinician-reported (CROMs) and patient-reported outcomes (PROMs) into a value-based care model.

Using lean methodology, post-stroke care pathways were mapped, and a harmonised workflow was implemented across 6 comprehensive stroke centres (CSCs) in Spain and Portugal. Consecutive patients discharged home or to socio-rehabilitation facilities with an mRS < 5 were offered participation. Follow-up was conducted via a smartphone app or telephone, enabling bidirectional communication with a case manager for health education, vital sign monitoring and PROMs collection. Feasibility required meeting 4 predefined indicators: inclusion > 60%, 3-month retention > 75%, PROMs completion > 60% and satisfaction > 70% measured by patient-reported experience measurement (PREM). Secondary analyses compared outcomes with historical cohorts.

Between 2022 and 2024, 4209 patients were recruited (40.2% women; median age 73 [IQR 62–81]; 75.6% ischaemic; median admission NIHSS 3 [1–6]; median discharge mRS 2 [1–3]). App use occurred in 59.9% (56% independently). Feasibility was achieved for inclusion (82.8%), retention (84.6%) and satisfaction (72.9%), but PROMs completion was 53.7% at 90 days. Despite mild severity, many reported suboptimal PROMs at 3 months, improving modestly by 1 year. Compared with historical controls, HARMONICS patients showed a better 3-month mRS distribution (OR 1.124; 95% CI, 1.042–1.213; P = .0026) and improved PROMs (P < .05).

HARMONICS is a feasible multicentre value-based follow-up model that promotes education, engagement and self-responsibility, with high rates of healthcare satisfaction reported by stroke survivors.

Graphical Abstract

## Linked entities

- **Diseases:** stroke (MONDO:0005098)

## Full-text entities

- **Genes:** FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}
- **Diseases:** Anxiety (MESH:D001007), ischemic heart disease (MESH:D017202), post-stroke complications (MESH:D008107), neurological disorders (MESH:D009461), hypertension (MESH:D006973), Extreme fatigue (MESH:D005221), chronic diseases (MESH:D002908), HVH (MESH:C538319), functional disability (MESH:D003291), atrial fibrillation (MESH:D001281), diabetes (MESH:D003920), ischaemic (MESH:D018917), Aphasia (MESH:D001037), acute (MESH:D000208), cognitive deficits (MESH:D003072), ischaemic or haemorrhagic stroke (MESH:D002543), Depression (MESH:D003866), Post-stroke (MESH:D020521), CSCs (MESH:D001308), TIA (MESH:D002546), post (MESH:D000094025), haemorrhagic (MESH:D006470)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12994693/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12994693/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12994693/full.md

---
Source: https://tomesphere.com/paper/PMC12994693